Therapeutic Advances in Endometriosis-Associated Infertility: From Conventional Hormonal Therapy To Linzagolix
This review summarizes clinical features, pathogenesis, and therapeutic approaches for endometriosis-associated infertility, contrasting conventional hormonal therapies with the GnRH antagonist linzagolix to address pain and fertility outcomes.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This review examines the multifactorial nature of endometriosis-associated infertility, detailing pathogenic mechanisms such as pelvic anatomical distortion, ovarian damage, and impaired embryo implantation. It evaluates conventional management strategies including hormonal therapies like ethinyl estradiol and levonorgestrel, alongside surgical interventions and assisted reproductive technologies. The paper also highlights Linzagolix, a GnRH receptor antagonist that suppresses estrogen production to alleviate pain symptoms, noting its potential role in treatment alongside add-back therapy for managing hypoestrogenic effects. This paper is centrally about endometriosis — specifically focusing on therapeutic advances for infertility associated with the condition.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,892 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (21)
- Classification of deep endometriosis (DE) including bowel endometriosis: From r-ASRM to #Enzian-classification via openalex
- Endometriosis via openalex
- Endometriosis and subfertility: is the relationship resolved? via openalex
- Endometriosis classification, staging and reporting systems: a review on the road to a universally accepted endometriosis classification via openalex
- Extra-pelvic endometriosis: A review via openalex
- Fertility and infertility: Definition and epidemiology via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Pathogenic mechanisms in endometriosis-associated infertility via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- Superficial Peritoneal Endometriosis: Clinical Characteristics of 203 Confirmed Cases and 1292 Endometriosis-Free Controls via openalex
- The search for genes contributing to endometriosis risk via openalex
- Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial via openalex
- W2734999847 via openalex
- W3134885188 via openalex
- W3208795377 via openalex
- W4214754424 via openalex
- W2095998027 via openalex
- W4234160457 via openalex
- W4295895755 via openalex
- W2950507227 via openalex
Source provenance
- openalex
- last seen: 2026-11-21T06:07:56.064915+00:00